BTG2 and cancer: Notably, the upregulation of miR-93-5p exhibited a greater prominence in MIBC than in NMIBC, potentially through the targeted inhibition of B-cell translocation gene 2 (BTG2) to promote cancer cell proliferation, migration, and invasion[64].